Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US11191753 | FERRING PHARMS INC | Liquid pharmaceutical composition |
Jun, 2034
(10 years from now) | |
US10624879 | FERRING PHARMS INC | Liquid pharmaceutical composition |
Jun, 2034
(10 years from now) | |
US9827231 | FERRING PHARMS INC | Liquid pharmaceutical composition |
Jun, 2034
(10 years from now) |
Market Authorisation Date: 28 November, 2017
Treatment: For cleansing of the colon as a preparation for colonoscopy; For cleansing the large intestine as a preparation for colonoscopy
Dosage: SOLUTION;ORAL
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8481083 | FERRING PHARMS INC | Granular compositions of magnesium oxide and citric acid and uses thereof |
Oct, 2028
(4 years from now) | |
US8450338 | FERRING PHARMS INC | Granular compositions of sodium picosulphate and potassium bicarbonate and uses thereof |
Oct, 2028
(4 years from now) |
Market Authorisation Date: 16 July, 2012
Treatment: NA
Dosage: FOR SOLUTION;ORAL